Trial Profile
Phase III Study of Z-206
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Apr 2018
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Kyowa Hakko Kirin; Zeria
- 05 Jul 2016 Status changed from active, no longer recruiting to completed.
- 04 Jun 2016 New trial record